Krajina: Írsko
Jazyk: angličtina
Zdroj: HMA (Heads of Medicines Agencies)
doramectin 10 mg/ml
Eli Lilly & Company Ltd
QP54AA03
Solution for injection
doramectin
Pigs
2011-01-12
Revised: December 2011 AN: 01227/2011 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Dectomax 10 mg/ml Solution for Injection for Pigs (UK) Zearl 10 mg/ml Solution for Injection for Pigs (IE) Dectomax® S 10 mg / ml Solution for Injection for Pigs (AT) Dectomax Vet., 10 mg/ml, Solution for Injection (Pigs) (DK) Zearl pigs (FR) Dectomax 10 mg/ml Solution for Injection for Pigs (BE, LU) Dectomax ® S Solution for Injection 10 mg / ml for Pigs (DE) Dectomax 10 mg/ml Solution for Injection for Pigs (ES) Dectomax for Pigs Vet. (SE) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml Dectomax Injection Solution 10 mg/ml contains the following: ACTIVE SUBSTANCE: Doramectin 10 mg (1) EXCIPIENT(S): Butylhydroxyanisole (E320) 0.1 mg (1) Contains no overage and assumes a potency of 100 percent. The actual amount of doramectin added will depend on the potency of the ingoing drug substance. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Colourless to pale yellow sterile oily solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For treatment of mange mites, gastrointestinal roundworms, lungworms, kidney worms and sucking lice in pigs. Gastrointestinal nematodes (adults and fourth stage larvae) _Hyostrongylus rubidus _ _ _ _Ascaris suum _ Revised: December 2011 AN: 01227/2011 Page 2 of 6 _Strongyloides ransomi Prečítajte si celý dokument